Memorial Sloan Kettering Cancer Center launched an initiative to improve cancer care and research through genomic analysis. The new program will reshape clinical trials and speed the translation of novel molecular discoveries into routine clinical practice. The Marie-Josée and Henry R. Kravis Center for Molecular Oncology will be funded through a $100 million gift, making it possible to realize the promise of precision oncology and support the development of new, individualized cancer therapies and diagnostic tools. Read more.
Memorial Sloan Kettering Cancer Center Receives $100M Gift
